Myogenic hyperuricemia: what can we learn from metabolic myopathies?
- PMID: 7603532
- DOI: 10.1002/mus.880181416
Myogenic hyperuricemia: what can we learn from metabolic myopathies?
Abstract
The association of muscle glycogenosis with hyperuricemia led to the identification of a unique purine disorder. Myogenic hyperuricemia is ascribed to excessive degradation of muscle purine nucleotides, secondary to impaired ATP generation. Although this pathophysiological condition has been observed not only in glycolytic defects but also in mitochondrial diseases affecting lipid and carbohydrate oxidation, it is most common and prominent in muscle phosphofructokinase deficiency, in which neither glycogen nor glucose can be used as metabolic fuels. The first key reaction of muscle purine degradation is catalysis by AMP deaminase. Numerous studies have indicated that AMP deaminase may play an important role in energy metabolism in contracting muscle. Arguments against this hypothesis have emerged through analyses on muscle AMP deaminase deficiency. According to a recent study, the mutant allele is extremely frequent among Caucasians and African-Americans, suggesting that many individuals with this enzyme defect may be clinically asymptomatic. Further study is required to explain the significance of muscle purine degradation in energy metabolism.
Similar articles
-
[Myogenic hyperuricemia].Nihon Rinsho. 1996 Dec;54(12):3343-8. Nihon Rinsho. 1996. PMID: 8976117 Review. Japanese.
-
Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V, and VII.N Engl J Med. 1987 Jul 9;317(2):75-80. doi: 10.1056/NEJM198707093170203. N Engl J Med. 1987. PMID: 3473284
-
Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle.J Clin Invest. 1984 Mar;73(3):720-30. doi: 10.1172/JCI111265. J Clin Invest. 1984. PMID: 6707201 Free PMC article.
-
Protecting the cellular energy state during contractions: role of AMP deaminase.J Physiol Pharmacol. 2006 Nov;57 Suppl 10:17-29. J Physiol Pharmacol. 2006. PMID: 17242488 Review.
-
A genetic defect in muscle phosphofructokinase deficiency, a typical clinical entity presenting myogenic hyperuricemia.Adv Exp Med Biol. 1991;309B:141-4. doi: 10.1007/978-1-4615-7703-4_32. Adv Exp Med Biol. 1991. PMID: 1838230 No abstract available.
Cited by
-
Association between uric acid and height during growth hormone therapy in children with idiopathic short stature.Front Endocrinol (Lausanne). 2022 Dec 2;13:1025005. doi: 10.3389/fendo.2022.1025005. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36531458 Free PMC article.
-
Inherited Neuromuscular Disorders: Which Role for Serum Biomarkers?Brain Sci. 2021 Mar 21;11(3):398. doi: 10.3390/brainsci11030398. Brain Sci. 2021. PMID: 33801069 Free PMC article. Review.
-
Fat-Free Mass Is Better Related to Serum Uric Acid Than Metabolic Homeostasis in Prader-Willi Syndrome.Nutrients. 2020 Aug 25;12(9):2583. doi: 10.3390/nu12092583. Nutrients. 2020. PMID: 32854398 Free PMC article.
-
Myopathies Related to Glycogen Metabolism Disorders.Neurotherapeutics. 2018 Oct;15(4):915-927. doi: 10.1007/s13311-018-00684-2. Neurotherapeutics. 2018. PMID: 30397902 Free PMC article. Review.
-
Metabolic profiles of exercise in patients with McArdle disease or mitochondrial myopathy.Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8402-8407. doi: 10.1073/pnas.1703338114. Epub 2017 Jul 17. Proc Natl Acad Sci U S A. 2017. PMID: 28716914 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical